NanoViricides
NNVC
41 hedge funds and large institutions have $5.54M invested in NanoViricides in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 12 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
1% more capital invested
Capital invested by funds: $5.47M → $5.54M (+$73K)
0.05% less ownership
Funds ownership: 0.33% → 0.28% (-0.05%)
20% less funds holding
Funds holding: 51 → 41 (-10)
83% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$118K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$101K |
| 3 |
Wolverine Trading
Chicago,
Illinois
|
+$21.1K |
| 4 |
Goldman Sachs
New York
|
+$14.9K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$6.93K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$135K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$86K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
-$84K |
| 4 |
Millennium Management
New York
|
-$73K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$50K |
NNVC Hedge Fund Activity: Q3 2016 in Review
41 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q3 2016, worth a combined $5.54M — up 1.3% from $5.47M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of NNVC and 2 opened new positions — a net loss of 10 holders — while 6 trimmed existing stakes and 8 added.
The largest buyer was Raymond James & Associates, opening a new position worth an estimated $118K. The largest seller was Deutsche Bank, exiting entirely with an estimated $135K sold.
- 41 institutional investors held NanoViricides (NNVC) as of Q3 2016, down from 51 in Q2 2016.
- Funds reported $5.54M of NanoViricides stock for Q3 2016, up 1.3% quarter-over-quarter.
- 2 funds opened new NanoViricides positions in Q3 2016 and 12 closed out, a net change of -10 holders.
- The largest NanoViricides buyer in Q3 2016 was Raymond James & Associates, an estimated $118K added.
- The largest NanoViricides seller in Q3 2016 was Deutsche Bank, an estimated $135K sold.
Based on aggregated 13F filings for Q3 2016.